Polaris Pharmaceuticals-KY Announces Audit Committee Member Changes
Polaris Pharmaceuticals-KY (6550) announced changes to its Audit Committee members on May 15, 115 (2026). The changes are due to the full re-election of directors, including independent directors, at the company's 2026 Annual General Meeting. The previous term for the independent directors was from September 26, 112 (2023) to June 11, 115 (2026). Zhao Ying-Cheng, an independent director, has been re-appointed. New independent directors appointed are Zhang Yi-Fang (Vice President of Mackay Taitung Branch), Zhang Zhi-Gang (CEO of Zhongen Biomedical), and Di Shi-Jie (Associate Professor at the University of Hong Kong). Zhao Ying-Cheng's brief biography is listed as former TSMC Plant Manager.
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 12:57
- 🔍 Collected: May 16, 2026 at 12:57 (0 min after Published)
- 🤖 AI Analyzed: May 16, 2026 at 14:45 (1h 48m after Collected)
Announcement Date: May 16, 115 (2026)
Statement Date: May 15, 115 (2026)
Statement Time: 21:16:27
Company Code: 6550
Company Name: Polaris Pharmaceuticals-KY
Subject: Announcement of the list of members of the company's Audit Committee
Compliance Clause: Clause 6
Date of Fact Occurrence: May 15, 115 (2026)
Explanation:
1. Date of Change: 115/05/15
2. Functional Committee Name: Audit Committee
3. Former Members:
Independent Director Zhao Ying-Cheng
Independent Director Wei Zong-De
Independent Director Wen (Ri Min) Guo Lan
Independent Director Zeng Guo-Hua
4. Brief Biographies of Former Members:
Independent Director Zhao Ying-Cheng / Independent Director of this company
Independent Director Wei Zong-De / Independent Director of this company
Independent Director Wen (Ri Min) Guo Lan / Independent Director of this company
Independent Director Zeng Guo-Hua / Independent Director of this company
5. New Members:
Independent Director Zhao Ying-Cheng
Independent Director Zhang Yi-Fang
Independent Director Zhang Zhi-Gang
Independent Director Di Shi-Jie
6. Brief Biographies of New Members:
Independent Director Zhao Ying-Cheng / Former TSMC Plant Manager
Independent Director Zhang Yi-Fang / Vice President of Mackay Taitung Branch
Independent Director Zhang Zhi-Gang / CEO of Zhongen Biomedical
Independent Director Di Shi-Jie / Associate Professor at the University of Hong Kong
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration
8. Reason for Change: Full re-election of directors (including independent directors) at the 2026 Annual General Meeting.
9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/09/26 ~ 115/06/11
10. Effective Date of New Appointment: 115/05/15
11. Other Matters to be Notified: None
Statement Date: May 15, 115 (2026)
Statement Time: 21:16:27
Company Code: 6550
Company Name: Polaris Pharmaceuticals-KY
Subject: Announcement of the list of members of the company's Audit Committee
Compliance Clause: Clause 6
Date of Fact Occurrence: May 15, 115 (2026)
Explanation:
1. Date of Change: 115/05/15
2. Functional Committee Name: Audit Committee
3. Former Members:
Independent Director Zhao Ying-Cheng
Independent Director Wei Zong-De
Independent Director Wen (Ri Min) Guo Lan
Independent Director Zeng Guo-Hua
4. Brief Biographies of Former Members:
Independent Director Zhao Ying-Cheng / Independent Director of this company
Independent Director Wei Zong-De / Independent Director of this company
Independent Director Wen (Ri Min) Guo Lan / Independent Director of this company
Independent Director Zeng Guo-Hua / Independent Director of this company
5. New Members:
Independent Director Zhao Ying-Cheng
Independent Director Zhang Yi-Fang
Independent Director Zhang Zhi-Gang
Independent Director Di Shi-Jie
6. Brief Biographies of New Members:
Independent Director Zhao Ying-Cheng / Former TSMC Plant Manager
Independent Director Zhang Yi-Fang / Vice President of Mackay Taitung Branch
Independent Director Zhang Zhi-Gang / CEO of Zhongen Biomedical
Independent Director Di Shi-Jie / Associate Professor at the University of Hong Kong
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration
8. Reason for Change: Full re-election of directors (including independent directors) at the 2026 Annual General Meeting.
9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/09/26 ~ 115/06/11
10. Effective Date of New Appointment: 115/05/15
11. Other Matters to be Notified: None
FAQ
What is the company code for Polaris Pharmaceuticals-KY?
The company code is 6550.
What was the reason for the change in the Audit Committee members?
The change was due to the full re-election of directors, including independent directors, at the company's 2026 Annual General Meeting.
Who are the newly appointed independent directors?
The newly appointed independent directors are Zhao Ying-Cheng, Zhang Yi-Fang, Zhang Zhi-Gang, and Di Shi-Jie.
What are the professional backgrounds of the new independent directors?
Zhao Ying-Cheng is listed as a former TSMC Plant Manager. Zhang Yi-Fang is the Vice President of Mackay Taitung Branch. Zhang Zhi-Gang is the CEO of Zhongen Biomedical. Di Shi-Jie is an Associate Professor at the University of Hong Kong.
What was the previous term for the independent directors?
The previous term was from September 26, 2023, to June 11, 2026.